U.S. Markets closed

Apyx Medical Corporation (APYX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.21-0.05 (-0.54%)
At close: 4:00PM EDT
9.21 0.00 (0.00%)
After hours: 04:00PM EDT

Apyx Medical Corporation

5115 Ulmerton Road
Clearwater, FL 33760
United States
727 384 2323

IndustryMedical Devices
Full Time Employees266

Key Executives

NameTitlePayExercisedYear Born
Mr. Charles D. Goodwin IIPres, CEO & Director637.81kN/A1966
Ms. Tara H. SembCFO, Treasurer & Sec.411.06kN/A1970
Mr. Moshe CitronowiczSr. VP366.25kN/A1953
Mr. Todd HornsbyExec. VP462.47kN/A1976
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and OEM. It offers electrosurgical generators based on its Helium Plasma Technology for cutting, coagulation, and ablation of soft tissue. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market that allows surgeons to operate with precision and eliminate unintended tissue trauma. It also develops, manufactures, and sells energy generators, disposable hand piece subassemblies, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Corporate Governance

Apyx Medical Corporation’s ISS Governance QualityScore as of June 1, 2021 is 6. The pillar scores are Audit: 10; Board: 6; Shareholder Rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.